OMCL:NSD-Omnicell Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 42.78

Change

-2.14 (-4.76)%

Market Cap

USD 1.99B

Volume

0.56M

Analyst Target

USD 81.29
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+1.74 (+2.00%)

USD 39.63B
HQY HealthEquity Inc

-1.26 (-1.60%)

USD 6.83B
RCM R1 RCM Inc

+0.02 (+0.14%)

USD 5.96B
GDRX Goodrx Holdings Inc

-0.24 (-3.16%)

USD 2.94B
BTSG BrightSpring Health Services, ..

+0.23 (+1.57%)

USD 2.37B
PRVA Privia Health Group Inc

+0.27 (+1.44%)

USD 2.23B
PINC Premier Inc

-0.05 (-0.24%)

USD 2.03B
CERT Certara Inc

+0.10 (+0.92%)

USD 1.76B
SDGR Schrodinger Inc

+0.10 (+0.51%)

USD 1.48B
MDRX Veradigm Inc.

-0.03 (-0.26%)

USD 1.04B

ETFs Containing OMCL

ROBE:LSE L&G ROBO Global Robotics .. 1.99 % 0.00 %

-0.10 (0.02%)

USD 0.69B
ROBG:LSE L&G ROBO Global Robotics .. 1.99 % 0.00 %

-14.50 (0.02%)

USD 0.69B
ROBO:LSE Legal & General UCITS ETF.. 1.99 % 0.00 %

-0.19 (0.02%)

USD 0.69B
HTEC Robo Global® Healthcare .. 1.97 % 0.00 %

-0.05 (0.02%)

USD 0.06B
XMLH:XETRA L&G Healthcare Breakthrou.. 1.93 % 0.00 %

-0.13 (0.02%)

USD 0.07B
XMLH:F Legal & General Ucits Etf.. 1.93 % 0.00 %

+0.06 (+0.02%)

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 1.93 % 0.00 %

-0.05 (0.02%)

USD 0.07B
DOCT:LSE L&G Healthcare Breakthrou.. 1.91 % 0.00 %

-0.15 (0.02%)

USD 0.07B
FSCC Federated Hermes ETF Trus.. 1.90 % 0.00 %

+0.01 (+0.02%)

N/A
DOCG:LSE L&G Healthcare Breakthrou.. 1.90 % 0.00 %

-12.75 (0.02%)

USD 0.07B
ROBO:AU ETFS ROBO Global Robotics.. 1.88 % 0.00 %

+0.29 (+0.02%)

USD 0.23B
IROB:XETRA L&G ROBO Global Robotics .. 1.84 % 0.00 %

-0.11 (0.02%)

USD 0.91B
ROBO:SW L&G ROBO Global Robotics .. 1.84 % 0.00 %

-0.05 (0.02%)

N/A
ROBO Robo Global® Robotics an.. 1.84 % 0.00 %

-0.17 (0.02%)

USD 1.09B
ROBO Robo Global® Robotics an.. 1.84 % 0.95 %

-0.17 (0.02%)

USD 1.09B
ISMD Inspire Small/Mid Cap Imp.. 0.31 % 0.62 %

-0.02 (0.02%)

USD 0.19B
SBB ProShares Short SmallCap6.. 0.00 % 0.95 %

N/A

N/A
SDD ProShares UltraShort Smal.. 0.00 % 0.95 %

-0.03 (0.02%)

N/A
XHE SPDR® S&P Health Care Eq.. 0.00 % 0.35 %

-0.11 (0.02%)

USD 0.22B
DMRS 0.00 % 0.45 %

N/A

N/A
IJR:AU iShares Core S&P SmallCap.. 0.00 % 0.00 %

+1.50 (+0.02%)

USD 0.54B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.69% 76% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.69% 76% C+ 72% C
Trailing 12 Months  
Capital Gain -20.54% 60% D- 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.54% 58% F 31% F
Trailing 5 Years  
Capital Gain -42.51% 55% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -42.51% 55% F 27% F
Average Annual (5 Year Horizon)  
Capital Gain -1.27% 62% D 40% F
Dividend Return -1.27% 62% D 36% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 61.36% 23% F 29% F
Risk Adjusted Return -2.06% 63% D 38% F
Market Capitalization 1.99B 84% B 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector